Leveraging functional genomics to reveal novel targets for cancer treatment supports research teams studying tumour heterogeneity to identify and validate more precise targets for cancer treatment.
Phase 1 including first-in-human clinical trials supports research teams testing biomarker-guided medicines or multi-modal treatments to establish early safety and efficacy for rare cancers.
Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research funds teams studying cancer care to improve equity.
Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies supports charities and agencies coordinating research to improve young cancer survivors’ well-being.
Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers supports cancer infrastructures to study diagnosis and treatment and improve access to care.
Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases supports teams validating AI biomarkers to improve care.